Delivery Order SPE2DB22D2006-SPE2DB25FW0ZN

Award Date 5/19/25
Potential Completion Date 5/20/25
Potential Value $1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,533.11, is for the delivery of Chloraseptic Sore 18s, a pharmaceutical product. The contract is a firm fixed-price delivery order with a performance period extending through May 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,111.64, is for the supply of 4,567,926,337 units of Chloraseptic sore throat lozenges. The contract has an ultimate completion date of April 16, 2025 and was awarded on April 15, 2025. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract worth $1,031.50 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Chloraseptic Max 15-10 mg lozenges. The contract has a completion date of February 7, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA Troop Support Medical with a potential value of $999,999,999.00 and a performance period through...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $6,275.63, is for the delivery of Chloraseptic Sore Throat Spray products. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of March 7, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, valued at $2,943.31, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of CHLORASEPTIC MAX 15-10 MG LOZ 15S, a pharmaceutical product. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
This federal contract award is a $2,347.30 firm fixed price delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The order is for the supply of CHLORASEPTIC MAX 15-10 MG LOZ 15S, a pharmaceutical product, with a completion date of February 8, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the procurement of CHLORASEPTIC MAX 15-10 MG LOZ 15S. The $13,759.31 firm fixed price delivery order does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor. The $1,195.20 firm fixed-price delivery order is for the supply of 4,561,837,661 Cepacol sore throat lozenges. The contract has an ultimate completion date of August 18, 2023. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for...
The Defense Logistics Agency awarded a $368 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 18 count packages of Chloraseptic sore throat lozenges. Performance will take place in Conshohocken, Pennsylvania over a one day period from August 7-8, 2023. As a major distributor of pharmaceuticals and medical supplies, Amerisourcebergen will fulfill this order to support the DLA's stocking of common over-the-counter medications for military treatment facilities and...
This federal contract award, with the ID SPE2DB22D2009|SPE2DB24FM1DJ, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, Corporate Office Division. The contract is for the delivery of 4565294520 ! CHLORASEPTIC MAX 15-10 MG LOZ 15S, a pharmaceutical product, with a firm fixed-price ceiling value of $1,871.90 and an ultimate completion date of July 31, 2024. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp, as one of...
  • SPE2DB22D2006
    Indefinite Delivery Contract
  • SPE2DB22D2006-SPE2DB25FW0ZN
    Delivery Order

This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Chloraseptic sore throat lozenges, with a ceiling value of $1,003.38 and a period of performance through May 20, 2025.

Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00 and designated as SPE2DX. This IDC provides a comprehensive global pharmaceutical support vehicle with a performance period extending through December 2026, enabling the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.

The contract award is not designated as a set-aside. Amerisourcebergen Drug Corp is a for-profit organization registered in the System for Award Management (SAM) and serves as a critical supplier of medical and pharmaceutical products to federal agencies, with a particular focus on the Defense Health Agency, U.S. Coast Guard, and other government customers.

Generated 8/24/25, 1:07 AM